BioCryst Pharmaceuticals (BCRX) stock Forecast for 2022 – 2026

BioCryst Pharmaceuticals (BCRX) stock Forecast for 2022 – 2026

Last update: November 27, 2022 (06:40)

Sector: Healthcare

The share price of BioCryst Pharmaceuticals, Inc. (BCRX) now

What analysts predict: $17.6

52-week high/low: $19.99 / $7.61

50/200 Day Moving Average: $13.15 / $12.93

This figure corresponds to the average price over the previous 50/200 days. For BioCryst Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For BioCryst Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in BioCryst Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BioCryst Pharmaceuticals stock price in 2022, 2023, 2024, 2025, 2026. How much will one BioCryst Pharmaceuticals share be worth in 2022 - 2026?

When should I take profit in BioCryst Pharmaceuticals stock? When should I record a loss on BioCryst Pharmaceuticals stock? What are analysts' forecasts for BioCryst Pharmaceuticals stock? What is the future of BioCryst Pharmaceuticals stock? We forecast BioCryst Pharmaceuticals stock performance using neural networks based on historical data on BioCryst Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BioCryst Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BioCryst Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of BioCryst Pharmaceuticals stock

The chart below shows the historical price of BioCryst Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BioCryst Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

BioCryst Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Nov 29 12.78 12.70 13.02 2.51
Nov 30 12.70 12.60 12.90 2.35
Dec 01 12.36 12.10 12.48 3.20
Dec 02 12.00 11.83 12.14 2.63
Dec 03 12.04 11.77 12.30 4.55
Dec 04 12.39 12.17 12.57 3.32
Dec 05 12.23 12.09 12.33 2.01
Dec 06 12.06 11.80 12.17 3.17
Dec 07 11.68 11.39 11.86 4.14
Dec 08 11.65 11.35 11.94 5.19
Dec 09 11.62 11.38 11.80 3.66
Dec 10 11.61 11.46 11.90 3.86
Dec 11 11.81 11.55 12.11 4.84
Dec 12 12.16 12.08 12.34 2.16
Dec 13 12.36 12.06 12.55 4.10
Dec 14 12.29 12.05 12.48 3.56
Dec 15 12.66 12.53 12.89 2.85
Dec 16 12.70 12.46 12.91 3.62
Dec 17 12.76 12.51 13.03 4.18
Dec 18 12.51 12.31 12.62 2.54
Dec 19 12.44 12.26 12.59 2.70
Dec 20 12.12 11.91 12.28 3.09
Dec 21 12.26 12.16 12.41 2.03
Dec 22 12.29 12.09 12.52 3.51
Dec 23 12.46 12.33 12.65 2.59
Dec 24 12.83 12.66 12.95 2.34
Dec 25 12.51 12.42 12.80 3.03
Dec 26 12.15 11.85 12.40 4.63
Dec 27 12.30 12.07 12.55 3.91
Dec 28 11.96 11.83 12.22 3.33

BioCryst Pharmaceuticals Daily Price Targets


BioCryst Pharmaceuticals Stock Forecast 11-29-2022.

Forecast target price for 11-29-2022: $12.78.
Positive dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.451%.
Pessimistic target level: 12.70
Optimistic target level: 13.02

BioCryst Pharmaceuticals Stock Forecast 11-30-2022.

Forecast target price for 11-30-2022: $12.70.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.300%.
Pessimistic target level: 12.60
Optimistic target level: 12.90

BioCryst Pharmaceuticals Stock Forecast 12-01-2022.

Forecast target price for 12-01-2022: $12.36.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 3.105%.
Pessimistic target level: 12.10
Optimistic target level: 12.48

BioCryst Pharmaceuticals Stock Forecast 12-02-2022.

Forecast target price for 12-02-2022: $12.00.
Negative dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 2.561%.
Pessimistic target level: 11.83
Optimistic target level: 12.14

BioCryst Pharmaceuticals Stock Forecast 12-03-2022.

Forecast target price for 12-03-2022: $12.04.
Positive dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 4.353%.
Pessimistic target level: 11.77
Optimistic target level: 12.30

BioCryst Pharmaceuticals Stock Forecast 12-04-2022.

Forecast target price for 12-04-2022: $12.39.
Positive dynamics for BioCryst Pharmaceuticals shares will prevail with possible volatility of 3.217%.
Pessimistic target level: 12.17
Optimistic target level: 12.57

BCRX (BCRX) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Dec. 11.83 11.23 12.36 9.08

BioCryst Pharmaceuticals forecast for this year


BioCryst Pharmaceuticals Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $11.8305. Pessimistic: $11.23. Optimistic: $12.36



BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 12.91 11.78 13.81 14.70
Feb 12.44 11.95 12.76 6.32
Mar 11.67 10.76 12.66 15.04
Apr 11.37 10.53 11.66 9.72
May 12.64 11.51 13.75 16.33
Jun 13.58 12.59 14.01 10.12
Jul 13.81 12.65 15.11 16.24
Aug 14.64 13.92 15.61 10.81
Sep 15.99 14.86 16.67 10.83
Oct 15.76 14.59 16.43 11.17
Nov 13.97 13.23 15.22 13.10
Dec 14.97 13.95 15.46 9.76

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 16.68 15.66 17.74 11.73
Feb 17.90 16.31 18.69 12.75
Mar 17.79 16.64 19.46 14.48
Apr 19.33 18.63 20.30 8.23
May 19.84 18.22 21.08 13.55
Jun 21.74 21.04 22.45 6.28
Jul 20.41 19.70 22.03 10.56
Aug 19.58 18.55 20.31 8.68
Sep 20.47 19.74 21.36 7.59
Oct 18.95 17.45 20.43 14.58
Nov 17.86 17.43 19.55 10.85
Dec 16.87 15.76 17.48 9.85

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 16.39 15.46 17.78 13.05
Feb 16.53 15.16 17.62 13.96
Mar 15.18 14.78 15.81 6.56
Apr 14.25 13.38 15.07 11.23
May 12.86 12.51 13.84 9.59
Jun 11.44 10.73 12.42 13.60
Jul 11.79 11.11 12.10 8.18
Aug 12.03 11.64 13.04 10.74
Sep 12.01 11.54 12.99 11.21
Oct 12.78 11.92 13.74 13.28
Nov 13.39 12.86 14.03 8.36
Dec 13.08 11.86 13.70 13.41

BioCryst Pharmaceuticals (BCRX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 13.92 13.35 14.52 8.05
Feb 15.37 14.15 16.35 13.43
Mar 15.15 13.80 16.51 16.40
Apr 15.04 14.68 16.19 9.36
May 15.47 14.12 16.68 15.36
Jun 16.29 15.88 16.93 6.23
Jul 16.37 15.46 16.78 7.84
Aug 16.94 15.55 18.44 15.65
Sep 17.97 17.46 18.99 8.07
Oct 19.85 18.54 20.64 10.16
Nov 21.28 19.44 22.12 12.12
Dec 22.91 21.62 24.18 10.58

BioCryst Pharmaceuticals information and performance

BioCryst Pharmaceuticals, Inc., a biotech company, is dedicated to the discovery of oral and small molecule drugs. The company markets injections of peramivir, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza, under the names RAPIVAB, ALPIVAB, RAPIACTA and PERAMIFLU; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for the treatment of peripheral T-cell lymphoma.

BioCryst Pharmaceuticals Address

4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, US

Market Capitalization: 2 328 436 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -160 088 992 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -0.28

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.072

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.85
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 10.96

Enterprise Value (EV) /Revenue

EV To EBITDA: -26.92

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 186424000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.